TCR stimulation drives cleavage and shedding of the ITIM receptor CD31

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5485-5492

  Fornasa, Giulia ^a   Groyer, Emilie ^a   Clement, Marc ^a   Dimitrov, Jordan ^b   Compain, Caroline ^a   Gaston, Anh Thu ^a   Varthaman, Aditi ^a   Khallou Laschet, Jamila ^a,c   Newman, Debra K ^e   Graff Dubois, Stéphanie ^a,d   Nicoletti, Antonino ^a,c   Caligiuri, Giuseppina ^a  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; PROTEIN TYROSINE PHOSPHATASE SHP 2; T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE; EXTRACELLULAR SPACE; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SYNTHESIS; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD31; CELL MEMBRANE; CELLS, CULTURED; EXTRACELLULAR SPACE; HUMANS; IMMUNOGLOBULINS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 77954732170     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902219     Document Type: Article

References (41)

1. Newman, P. J. 1999. Switched at birth: a new family for PECAM-1. J. Clin. Invest. 103: 5-9.
2. Newman, P. J., M. C. Berndt, J. Gorski, G. C. White, II, S. Lyman, C. Paddock, and W. A. Muller. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247: 1219-1222. (Pubitemid 20102483)
3. Muller, W. A., S. A. Weigl, X. Deng, and D. M. Phillips. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178: 449-460.
4. Bird, I. N., J. H. Spragg, A. Ager, and N. Matthews. 1993. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80: 553-560.
5. Tada, Y., S. Koarada, F. Morito, O. Ushiyama, Y. Haruta, F. Kanegae, A. Ohta, A. Ho, T. W. Mak, and K. Nagasawa. 2003. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis Rheum. 48: 3280-3290.
6. Brown, S., I. Heinisch, E. Ross, K. Shaw, C. D. Buckley, and J. Savill. 2002. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418: 200-203. (Pubitemid 34773776)
7. Newton-Nash, D. K., and P. J. Newman. 1999. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J. Immunol. 163: 682-688.
8. Graesser, D., A. Solowiej, M. Bruckner, E. Osterweil, A. Juedes, S. Davis, N. H. Ruddle, B. Engelhardt, and J. A. Madri. 2002. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109: 383-392.
9. Wong, M. X., J. D. Hayball, P. M. Hogarth, and D. E. Jackson. 2005. The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J. Clin. Immunol. 25: 19-28.
10. Goel, R., B. R. Schrank, S. Arora, B. Boylan, B. Fleming, H. Miura, P. J. Newman, R. C. Molthen, and D. K. Newman. 2008. Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28: 1996-2002.
11. Stockinger, H., W. Schreiber, O. Majdic, W. Holter, D. Maurer, and W. Knapp. 1992. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology 75: 53-58.
12. Thiel, A., J. Schmitz, S. Miltenyi, and A. Radbruch. 1997. CD45RA-expressing memory/effector Th cells committed to production of interferon-gamma lack expression of CD31. Immunol. Lett. 57: 189-192.
13. Demeure, C. E., D. G. Byun, L. P. Yang, N. Vezzio, and G. Delespesse. 1996. CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 88: 110-115.
14. Kohler, S., and A. Thiel. 2009. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 113: 769-774.
15. Goldberger, A., K. A. Middleton, J. A. Oliver, C. Paddock, H. C. Yan, H. M. DeLisser, S. M. Albelda, and P. J. Newman. 1994. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem. 269: 17183-17191.
16. Zehnder, J. L., K. Hirai, M. Shatsky, J. L. McGregor, L. J. Levitt, and L. L. Leung. 1992. The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J. Biol. Chem. 267: 5243-5249.
17. Ilan, N., A. Mohsenin, L. Cheung, and J. A. Madri. 2001. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J. 15: 362-372.
18. Yun, P. L., A. A. Decarlo, C. C. Chapple, and N. Hunter. 2005. Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. Infect. Immun. 73: 1386-1398.
19. Garton, K. J., P. J. Gough, J. Philalay, P. T. Wille, C. P. Blobel, R. H. Whitehead, P. J. Dempsey, and E. W. Raines. 2003. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J. Biol. Chem. 278: 37459-37464.
20. Mendez, M. P., S. B. Morris, S. Wilcoxen, E. Greeson, B. Moore, and R. Paine, III. 2006. Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L962-L970.
21. Eugenin, E. A., R. Gamss, C. Buckner, D. Buono, R. S. Klein, E. E. Schoenbaum, T. M. Calderon, and J. W. Berman. 2006. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J. Leukoc. Biol. 79: 444-452.
22. Fawcett, J., C. Buckley, C. L. Holness, I. N. Bird, J. H. Spragg, J. Saunders, A. Harris, and D. L. Simmons. 1995. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J. Cell Biol. 128: 1229-1241.
23. Yan, H. C., J. M. Pilewski, Q. Zhang, H. M. DeLisser, L. Romer, and S. M. Albelda. 1995. Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping. Cell Adhes. Commun. 3: 45-66.
24. Caligiuri, G., E. Groyer, J. Khallou-Laschet, A. Al Haj Zen, J. Sainz, D. Urbain, A. T. Gaston, M. Lemitre, A. Nicoletti, and A. Lafont. 2005. Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler. Thromb. Vasc. Biol. 25: 1659-1664.
25. In vivo assays for lymphocyte function. 2001. In Current Protocols in Immunology. Shevach, E. M., J. E. Coligan, B. Bierer, and D. H. Margulies. John Wiley & Sons. Unit 4.5.
26. Zehnder, J. L., M. Shatsky, L. L. Leung, E. C. Butcher, J. L. McGregor, and L. J. Levitt. 1995. Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood 85: 1282-1288.
27. Caligiuri, G., P. Rossignol, P. Julia, E. Groyer, D. Mouradian, D. Urbain, N. Misra, V. Ollivier, M. Sapoval, P. Boutouyrie, et al. 2006. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 26: 618-623.
28. Chen, Y., P. G. Schlegel, N. Tran, D. Thompson, J. L. Zehnder, and N. J. Chao. 1997. Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease. Blood 89: 1452-1459. (Pubitemid 27080011)
29. Muller, W. A., M. E. Berman, P. J. Newman, H. M. DeLisser, and S. M. Albelda. 1992. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J. Exp. Med. 175: 1401-1404.
30. Vernon-Wilson, E. F., F. Auradé, and S. B. Brown. 2006. CD31 promotes beta1 integrin-dependent engulfment of apoptotic Jurkat T lymphocytes opsonized for phagocytosis by fibronectin. J. Leukoc. Biol. 79: 1260-1267.
31. Wong, C. W., G. Wiedle, C. Ballestrem, B. Wehrle-Haller, S. Etteldorf, M. Bruckner, B. Engelhardt, R. H. Gisler, and B. A. Imhof. 2000. PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol. Biol. Cell 11: 3109-3121.
32. Sachs, U. J., C. L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V. V. Orlova, E. Y. Choi, P. J. Newman, K. T. Preissner, T. Chavakis, and S. Santoso. 2007. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J. Biol. Chem. 282: 23603-23612.
33. Newton, J. P., C. D. Buckley, E. Y. Jones, and D. L. Simmons. 1997. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J. Biol. Chem. 272: 20555-20563.
34. Couty, J. P., C. Rampon, M. Leveque, M. P. Laran-Chich, S. Bourdoulous, J. Greenwood, and P. O. Couraud. 2007. PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J. Neurochem. 103: 793-801.
35. Newman, P. J., and D. K. Newman. 2003. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler. Thromb. Vasc. Biol. 23: 953-964.
36. Khare, A., S. Shetty, K. Ghosh, D. Mohanty, and S. Chatterjee. 2005. Evaluation of markers of endothelial damage in cases of young myocardial infarction. Atherosclerosis 180: 375-380.
37. Wei, H., L. Fang, S. H. Chowdhury, N. Gong, Z. Xiong, J. Song, K. H. Mak, S.Wu, E. Koay, S. Sethi, et al. 2004. Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with severe coronary artery stenosis in Chinese Singaporean. Clin. Biochem. 37: 1091-1097.
38. Kuenz, B., A. Lutterotti, M. Khalil, R. Ehling, C. Gneiss, F. Deisenhammer, M. Reindl, and T. Berger. 2005. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J. Neuroimmunol. 167: 143-149.
39. Figarella-Branger, D., N. Schleinitz, B. Boutière-Albanèse, L. Camoin, N. Bardin, S. Guis, J. Pouget, C. Cognet, J. F. Pellissier, and F. Dignat-George. 2006. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J. Rheumatol. 33: 1623-1630.
40. Goel, R., B. Boylan, L. Gruman, P. J. Newman, P. E. North, and D. K. Newman. 2007. The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1205-G1214.
41. Groyer, E., A. Nicoletti, H. Ait-Oufella, J. Khallou-Laschet, A. Varthaman, A. T. Gaston, O. Thaunat, S. V. Kaveri, R. Blatny, H. Stockinger, et al. 2007. Atheroprotective effect of CD31 receptor globulin through enrichment of circulating regulatory T-cells. J. Am. Coll. Cardiol. 50: 344-350.